Based on this feature, TAGLN is widely considered to have tumor suppressor effects (44), and further studies have shown that TAGLN may not only serve as a potential diagnostic biomarker for bladder cancer (BCa), but may also be a promising therapeutic target (45). The gene discussed is TAGLN; the disease is urinary bladder carcinoma.